Patent details

EP2761299 Title: MUTATIONS IN SF3B1 AND CHRONIC LYMPHOCYTIC LEUKEMIA

Basic Information

Publication number:
EP2761299
PCT Application Number:
PCT/US/2012/058164
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP127755759
PCT Publication Number:
WO/2013/049750
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
MUTATIONS IN SF3B1 AND CHRONIC LYMPHOCYTIC LEUKEMIA
French Title of Invention:
MUTATIONS DANS SF3B1 ET LEUCÉMIE LYMPHOÏDE CHRONIQUE
German Title of Invention:
SF3B1-MUTATIONEN UND CHRONISCHE LYMPHATISCHE LEUKÄMIE
SPC Number:

Dates

Filing date:
29/09/2012
Grant date:
26/10/2016
EP Publication Date:
26/10/2016
PCT Publication Date:
04/04/2013
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
06/08/2014
EP B1 Publication Date:
26/10/2016
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
29/09/2017
Expiration date:
29/09/2032
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
29/09/2012
 
 

Name:
Trovagene Inc.
Address:
11055 Flintkote Ave. Suite B, San Diego, California 92121, United States (US)

Inventor

1

Name:
GAIDANO Gianluca
Address:
United States (US)

2

Name:
FOA Robert
Address:
United States (US)

3

Name:
ROSSI Davide
Address:
United States (US)

Priority

Priority Number:
201161540618
Priority Date:
29/09/2011
Priority Country:
United States (US)

Classification

Main IPC Class:
G01N 33/574;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages